James E. Fickenscher, Chief Financial Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 17,769 shares at $0.60 ($11K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $11k ZYNE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |
| ZYNE | BUY | 2016-12-08 | $99K | — | Filing → |